Work

The challenges of checkpoint inhibition in the treatment of multiple myeloma

Year: 2018

Type: review

Source: Cellular Immunology

DOI: 10.1016/j.cellimm.2018.10.003

Authors: Barry Paul, Shuqi Kang, Zhihong Zheng, Yubin Kang

Institutions: Duke University, Duke Medical Center, Peoria campus of the University of Illinois System, Fujian Medical University, Union Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: Targeting sphingosine kinase 2 for the treatment of multiple myeloma, Clinical Trial of ABC294640 in Patients with Refractory Multiple Myeloma, Plerixafor for allogeneic hematopoietic stem cell transplantation, Hematology & Transfusion Medicine

OpenAlex ID: W2896508736

FWCI: 0.454

Cites: 171

Cited by: 22

Related to: 10